MIMS Full Prescribing Update
New / Revised |
Product Name |
Section changed |
---|---|---|
New | APO-Ramipril Capsules | |
New | Biktarvy Blister | |
New | Chemists' Own Day + Night Cold & Flu Relief PE | |
New | Chemists' Own Day+ Night Cold & Flu Relief | |
New | Comirnaty (Tris/Sucrose Presentation) | |
New | Dasatinib ARX | |
New | Demazin Allergy + Hayfever Relief | |
New | Demazin Cold + Flu + Cough Day + Night | |
New | Dinasane | |
New | Fludrocortisone Medsurge | |
New | Fulvestrant Accord | |
New | Parapane Osteo | |
New | Phebra Calcium Gluconate 931 mg/10 mL Injection | |
New | Rukobia | |
New | Tacrolimus APOTEX | |
New | Vinorelbine Injection USP (Sagent) | |
New | Vyepti | |
New | Zejula | |
New | Zoledronic Acid SUN | |
Revised | 3TC | Overdose, Special Warnings and Precautions for Use |
Revised | Acnatac | Nature and Contents of Container, Qualitative and Quantitative Composition |
Revised | Actemra | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Nature and Contents of Container, New indication, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Actos | TGA Date |
Revised | Adenuric | Nature and Contents of Container |
Revised | Allereze | Nature and Contents of Container, Qualitative and Quantitative Composition |
Revised | Alprolix | Adverse Effects (Undesirable Effects), Pharmacological Properties, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use |
Revised | Alustal House Dust Mites Extract | List of Excipients, Nature and Contents of Container |
Revised | Alustal Pollen Extract of Five Grasses | List of Excipients, Nature and Contents of Container |
Revised | Alustal Olive Tree Pollen Extract | List of Excipients, Nature and Contents of Container |
Revised | Amdarone | Pharmaceutical Form |
Revised | Amiloxyn | Adverse Effects (Undesirable Effects), Qualitative and Quantitative Composition |
Revised | Amoxil Oral | TGA Date |
Revised | APO-Amoxycillin Capsules | Adverse Effects (Undesirable Effects), Qualitative and Quantitative Composition |
Revised | APO-Amoxycillin Powder for Suspension | Adverse Effects (Undesirable Effects) |
Revised | APO-Lansoprazole ODT | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Aptivus | Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | APX-Celecoxib | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | APX-Olmesartan | TGA Date |
Revised | Arimidex | Adverse Effects (Undesirable Effects) |
Revised | Aromasin | Adverse Effects (Undesirable Effects) |
Revised | Biktarvy Bottle | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Biological Therapies Thiamine Hydrochloride | Nature and Contents of Container |
Revised | Blackmores Vitamin B6 | Adverse Effects (Undesirable Effects), Deleted Presentation, New Presentation of Brand already available, Special Warnings and Precautions for Use |
Revised | Blooms the Chemist Celecoxib | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | Braltus | Special Warnings and Precautions for Use |
Revised | Bridion | Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Celapram | Adverse Effects (Undesirable Effects), Nature and Contents of Container, Special Warnings and Precautions for Use |
Revised | Celexi | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | CellCept | Special Warnings and Precautions for Use |
Revised | Cipla Meloxicam | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | Codapane Forte 500/30 | Adverse Effects (Undesirable Effects), Overdose, Qualitative and Quantitative Composition |
Revised | Comfarol Forte | Adverse Effects (Undesirable Effects), Qualitative and Quantitative Composition |
Revised | Condyline Paint | TGA Date |
Revised | Cordarone X | Pharmaceutical Form, Pharmaceutical Form |
Revised | Cordarone X Intravenous | Pharmaceutical Form, Pharmaceutical Form |
Revised | Coregas Medical Nitrous Oxide | Nature and Contents of Container |
Revised | Curosurf | TGA Date |
Revised | Darunavir JUNO | Contraindications, Interactions with Other Medicines and Other Forms of Interactions |
Revised | DBL Amikacin Injection | Adverse Effects (Undesirable Effects), Contraindications, Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Nature and Contents of Container, Pharmaceutical Form, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use |
Revised | DBL Ciprofloxacin Injection For Intravenous Infusion | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | DBL Vincristine Sulfate Injection | Sponsor |
Revised | Denpax | Pharmaceutical Form |
Revised | Descovy | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Dilantin | TGA Date |
Revised | Dizole | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Nature and Contents of Container |
Revised | Dymista 125/50 | Nature and Contents of Container |
Revised | Eikance | Nature and Contents of Container |
Revised | EllaOne | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Overdose, Qualitative and Quantitative Composition |
Revised | Eloctate | Adverse Effects (Undesirable Effects), Pharmaceutical Form, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Endep | TGA Date |
Revised | EpiPen | Nature and Contents of Container, Qualitative and Quantitative Composition |
Revised | EpiPen Jr | Nature and Contents of Container, TGA Date |
Revised | Esomeprazole Sandoz Hp7 | Adverse Effects (Undesirable Effects) |
Revised | Evrysdi | Adverse Effects (Undesirable Effects) |
Revised | Fenofibrate Viatris | Product Name change, TGA Date |
Revised | Fenofibrate Viatris | TGA Date |
Revised | Genvoya | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Gilmat | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Grazax | Adverse Effects (Undesirable Effects) |
Revised | Hydralyte | Presentation |
Revised | Hysone | Nature and Contents of Container |
Revised | Imatinib RBX | Adverse Effects (Undesirable Effects), Dose and Method of Administration, New indication, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Imbruvica | Adverse Effects (Undesirable Effects) |
Revised | Imovane | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Imrest | Qualitative and Quantitative Composition, Sponsor |
Revised | Infanrix Hexa (thiomersal free) | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Nature and Contents of Container, Pharmacological Properties |
Revised | Inza | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | Ipol | Special Warnings and Precautions for Use |
Revised | Ketoral Injection | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Nature and Contents of Container, Special Warnings and Precautions for Use |
Revised | Keytruda | Dose and Method of Administration |
Revised | Lipidil | Nature and Contents of Container, Qualitative and Quantitative Composition, Sponsor |
Revised | Logem | Qualitative and Quantitative Composition |
Revised | Lunava | TGA Date |
Revised | Mektovi | Pharmacological Properties |
Revised | Meloxicam Sandoz | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | Mersyndol | Adverse Effects (Undesirable Effects) |
Revised | Mersyndol Forte | Adverse Effects (Undesirable Effects) |
Revised | Montelukast APOTEX | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Montelukast Lupin | Adverse Effects (Undesirable Effects), Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Montelukast Mylan | Adverse Effects (Undesirable Effects), Effects on Ability to Drive and Use Machines, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Montelukast Sandoz | Adverse Effects (Undesirable Effects), Effects on Ability to Drive and Use Machines, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Navelbine Oral | TGA Date |
Revised | Nimotop | Interactions with Other Medicines and Other Forms of Interactions, Nature and Contents of Container, Special Precautions for Storage, Special Warnings and Precautions for Use |
Revised | Noxafil | Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Noxafil Concentrated Injection | Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Nplate | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Qualitative and Quantitative Composition, Therapeutic Indications |
Revised | Nubeqa | Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Nature and Contents of Container, Pharmacological Properties |
Revised | Odefsey | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Olmesartan HCT-MYL | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Olmetec Plus | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Omacor | TGA Date |
Revised | Omnipaque (Intrathecal) | Nature and Contents of Container, Nature and Contents of Container, Special Precautions for Disposal, Special Precautions for Disposal |
Revised | Omnipaque (Intravascular, Oral and Body Cavities) | Nature and Contents of Container, Nature and Contents of Container, Special Precautions for Disposal, Special Precautions for Disposal |
Revised | Opdivo | Adverse Effects (Undesirable Effects), Dose and Method of Administration, New indication, Pharmacological Properties |
Revised | Painstop Day-Time Pain Reliever | TGA Date |
Revised | Painstop Night-Time Pain Reliever | TGA Date |
Revised | Panadeine Forte | Adverse Effects (Undesirable Effects) |
Revised | Patent Blue V | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Periactin | Nature and Contents of Container |
Revised | Phentermine GH | List of Excipients |
Revised | Pitressin | TGA Date |
Revised | Polivy | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Physicochemical Properties, Special Warnings and Precautions for Use |
Revised | Prezista | Contraindications, Interactions with Other Medicines and Other Forms of Interactions |
Revised | Prodeine Forte | Adverse Effects (Undesirable Effects) |
Revised | Quetiapine Sandoz Pharma | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Rapamune | Nature and Contents of Container |
Revised | Relpax | List of Excipients, Nature and Contents of Container, Pharmaceutical Form, Qualitative and Quantitative Composition |
Revised | Setrona | Adverse Effects (Undesirable Effects), Contraindications, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Spikevax | Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Fertility, Pregnancy and Lactation, Nature and Contents of Container, Pharmacological Properties, Qualitative and Quantitative Composition, Shelf Life, Special Warnings and Precautions for Use |
Revised | Spiractin | Nature and Contents of Container, Qualitative and Quantitative Composition |
Revised | Symtuza | Contraindications, Interactions with Other Medicines and Other Forms of Interactions |
Revised | Tamoxifen Sandoz | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Terlipressin Ever Pharma | Contraindications, Special Warnings and Precautions for Use |
Revised | Tobi, Tobi Podhaler | Nature and Contents of Container, Pharmaceutical Form |
Revised | Tobramycin Mylan | Adverse Effects (Undesirable Effects), Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Overdose, Pharmaceutical Form, Special Warnings and Precautions for Use |
Revised | Trazimera | Dose and Method of Administration |
Revised | Triasyn | Nature and Contents of Container |
Revised | Triumeq | Interactions with Other Medicines and Other Forms of Interactions |
Revised | Tysabri | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Nature and Contents of Container, Pharmaceutical Form, Pharmacological Properties, Qualitative and Quantitative Composition, Special Precautions for Storage, Special Warnings and Precautions for Use |
Revised | Ultravist | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Vaxigrip Tetra | Qualitative and Quantitative Composition |
Revised | Vaxzevria | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Vemlidy | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Vfend | Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Special Warnings and Precautions for Use |
Revised | Viagra | List of Excipients |
Revised | Xevudy | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Zavicefta | Dose and Method of Administration |
Revised | Zepzelca | TGA Date |
Deleted | Abacavir/Lamivudine GH 600/300 | |
Deleted | Adefin XL | |
Deleted | Afeme Duo | |
Deleted | APO-Aciclovir | |
Deleted | APO-Celecoxib | |
Deleted | APO-Clopidogrel Blister | |
Deleted | APO-Clopidogrel Bottle | |
Deleted | APO-Clopidogrel/Aspirin | |
Deleted | APO-Cyproterone Acetate 50 mg | |
Deleted | APO-Flucloxacillin | |
Deleted | APO-Fluconazole One | |
Deleted | APOHealth Budesonide Hayfever | |
Deleted | APO-Letrozole | |
Deleted | APO-Mycophenolate Tablets | |
Deleted | APO-Paroxetine | |
Deleted | APO-Ranitidine | |
Deleted | APO-Riluzole | |
Deleted | APO-Rizatriptan | |
Deleted | APO-Rosuvastatin | |
Deleted | APO-Sildenafil | |
Deleted | Aripiprazole Generichealth | |
Deleted | Aripiprazole GH | |
Deleted | Azathioprine AN | |
Deleted | BTC Fluoxetine | |
Deleted | Cancidas | |
Deleted | Capecitabine APOTEX | |
Deleted | Cerdelga | |
Deleted | Darunavir Mylan | |
Deleted | Dimetapp PE Sinus Pain Tablets | |
Deleted | Famciclovir Mylan | |
Deleted | Famciclovir Mylan Cold Sore Relief | |
Deleted | Gantin | |
Deleted | GenRx Alprazolam | |
Deleted | Imogam Rabies Pasteurized | |
Deleted | Kosteo | |
Deleted | Lynparza Capsules | |
Deleted | Magnesium Opti-Tabs | |
Deleted | Mersyndol DayStrength | |
Deleted | Panadol (Children) 7+ Years Soluble Tablets | |
Deleted | Perindopril APOTEX | |
Deleted | Simvastatin Generichealth | |
Deleted | Verapamil Mylan |
Copyright © MIMS Australia Pty Ltd. All rights reserved.
MIMS Australia
Suite 302, Level 3, 53 Berry Street
North Sydney NSW 2060
Phone: 1800 800 629
info@mims.com.au
www.mims.com.au